Martin J Thomas

US Patent:

20050019376, Jan 27, 2005

Filed:

Sep 28, 2002

Appl. No.:

10/476503

Inventors:

Gerard McNally - Nerwyn PA, US
Frank Bunick - Randolph NJ, US
Harry Sowden - Glenside PA, US
Gus LaBella - Collegeville PA, US
Timothy Gilmor - Orefield PA, US
Martin Thomas - Lake Worth FL, US

International Classification:

A61K009/68

US Classification:

424440000

Abstract:

A dosage form comprises an active ingredient and a confectionery composition. In one embodiment the relative standard deviation of the weight of the dosage form is less than 1%, and the dosage form has at least one face. In another embodiment, a dosage form comprising an active ingredient and a confectionery composition wherein the dosage form has at least one face, does not have a free formed surface, and has a mean polarized light transmission at the angle of maximum extinction which is not greater than the mean polarized light transmission of the dosage form at the angle of maximum transmission. The active ingredient may be a pharmaceutically active agent.

US Patent:

20090186082, Jul 23, 2009

Filed:

Jan 27, 2009

Appl. No.:

12/360579

Inventors:

David Wynn - Huntington Valley PA, US
Narendra Parikh - Long Valley NJ, US
Dan McTeigue - North Wales PA, US
Harry S. Sowden - Glenside PA, US
Martin Thomas - Lake Worth FL, US

International Classification:

A61K 9/22

US Classification:

424472

Abstract:

In one embodiment, a dosage form comprises: (a) at least one active ingredient; (b) a molded core which is solid at room temperature; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment of this invention, a dosage form comprises: (a) at least one active ingredient; (b) a molded core comprising a plurality of particles; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium.